title: Reply to: 'Four quadrant sclerotomies for uveal effusion syndrome'.
authors.affiliation: Department of Ophthalmology, University Clinical Centre 'Sestre milosrdnice', Zagreb, Croatia.
authors.forename: B
authors.initials: B
authors.lastname: Andrijević Derk
authors.affiliation: Department of Ophthalmology, University Clinical Centre 'Sestre milosrdnice', Zagreb, Croatia.
authors.forename: G
authors.initials: G
authors.lastname: Benčić
authors.affiliation: Department of Ophthalmology, General Hospital, Vinkovci, Croatia.
authors.forename: V
authors.initials: V
authors.lastname: Corluka
authors.affiliation: Department of Ophthalmology, University Clinical Centre 'Sestre milosrdnice', Zagreb, Croatia.
authors.forename: M
authors.initials: M
authors.lastname: Zorić Geber
authors.affiliation: Department of Ophthalmology, University Clinical Centre 'Sestre milosrdnice', Zagreb, Croatia.
authors.forename: Z
authors.initials: Z
authors.lastname: Vatavuk
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D015862:Choroid Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D012163:Retinal Detachment / Q000188:drug therapy*; D014603:Uveal Diseases / Q000188:drug therapy*
chemical_list: D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D011461:Prostaglandins F, Synthetic; D000086:Acetazolamide